Matthias Luz

1.7k total citations
16 papers, 977 citations indexed

About

Matthias Luz is a scholar working on Surgery, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Matthias Luz has authored 16 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Matthias Luz's work include Heparin-Induced Thrombocytopenia and Thrombosis (4 papers), Nerve injury and regeneration (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Matthias Luz is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (4 papers), Nerve injury and regeneration (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Matthias Luz collaborates with scholars based in Germany, United States and United Kingdom. Matthias Luz's co-authors include Andreas Greinacher, Petra Eichler, Norbert Lübenow, Uwe Janssens, B. Kemkes‐Matthes, Günther Berg, Markus Böck, Bernd Pötzsch, Erich Mohr and Michael Kirchengast and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Matthias Luz

16 papers receiving 939 citations

Peers

Countries citing papers authored by Matthias Luz

Since Specialization

Citations

This map shows the geographic impact of Matthias Luz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Luz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Luz more than expected).

Fields of papers citing papers by Matthias Luz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Luz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Luz. The network helps show where Matthias Luz may publish in the future.

Co-authorship network of co-authors of Matthias Luz

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Luz. A scholar is included among the top collaborators of Matthias Luz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Luz. Matthias Luz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop 2024 ·Journal of Parkinson s Disease ·Roger A. Barker, Märt Saarma, Clive N. Svendsen, Catherine Morgan, Alan Whone, Massimo S. Fiandaca, Matthias Luz, Krystof S. Bankiewicz, Brian Fiske, (unknown), Arthur Roach, (unknown), Jeffrey H. Kordower, Emma L. Lane, Henri J. Huttunen, Aideen M. Sullivan, Gerard W. O’Keeffe, (unknown), Howard J. Federoff	3
2	The Parkinson’s Disease Comprehensive Response (PDCORE): a composite approach integrating three standard outcome measures 2020 ·Brain Communications ·Matthias Luz, Alan Whone, (unknown), Richard Wyse, Glenn T. Stebbins, Erich Mohr	6
3	Intermittent convection-enhanced delivery of GDNF into rhesus monkey putamen: absence of local or cerebellar toxicity 2018 ·Archives of Toxicology ·Matthias Luz, (unknown), John R. Bringas, (unknown), (unknown), Kristen J. Nikula, Owen Lewis, Max Woolley, H.C. Fibiger, Krystof S. Bankiewicz, Erich Mohr	11
4	GDNF-induced cerebellar toxicity: A brief review 2015 ·NeuroToxicology ·Matthias Luz, Erich Mohr, H.C. Fibiger	31
5	Clearance and Toxicity of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHu GDNF) Following Acute Convection-Enhanced Delivery into the Striatum 2013 ·PLoS ONE ·Hannah Taylor, Neil U. Barua, Alison Bienemann, Marcella Wyatt, (unknown), Rebecca R. Foster, Matthias Luz, (unknown), Erich Mohr, Steven S. Gill	23
6	Design of an in-dwelling cannula for convection-enhanced delivery 2010 ·Journal of Neuroscience Methods ·Kathryn H. Rosenbluth, Matthias Luz, Erich Mohr, Stephan Mittermeyer, John R. Bringas, Krystof S. Bankiewicz	21
7	Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience 2009 ·Journal of Neuro-Oncology ·Amy Grahn, Krystof S. Bankiewicz, Millicent M. Dugich‐Djordjevic, John R. Bringas, Piotr Hadaczek, Greg A. Johnson, Simon J. Eastman, Matthias Luz	39
8	Endothelin Receptor Antagonists 2005 ·Journal of Cardiovascular Pharmacology ·Michael Kirchengast, Matthias Luz	32
9	Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range 2000 ·Blood ·Andreas Greinacher, Petra Eichler, Norbert Lübenow, (unknown), Matthias Luz	235
10	Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range 2000 ·Blood ·Andreas Greinacher, Petra Eichler, Norbert Lübenow, (unknown), Matthias Luz	229
11	Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced Thrombocytopenia 1999 ·Circulation ·Andreas Greinacher, Uwe Janssens, Günther Berg, Markus Böck, (unknown), B. Kemkes‐Matthes, Petra Eichler, (unknown), Bernd Pötzsch, Matthias Luz	264
12	Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina 1995 ·Journal of the American College of Cardiology ·(unknown), Wolfram Terres, (unknown), Matthias Luz, Andreas Jessel, Gerd Häfner, Jürgen vom Dahl, (unknown), W. Prellwitz, Jürgen Meyer	37
13	Angiographic dose-finding study with r-hirudin (HBW 023) for the improvement of thrombolytic therapy with streptokinase (HIT-SK) Interim results 1995 ·European Heart Journal ·G. P. Molhoek, GertJan Laarman, Dirk J. Lok, Matthias Luz, J.Herre Kingma, Arjan A. van den Bos, (unknown), (unknown), (unknown), (unknown)	12
14	Hemodynamic and respiratory effects of pneumoperitoneum and PEEP during laparoscopic pelvic lymphadenectomy in dogs 1994 ·Surgical Endoscopy ·Matthias Luz, (unknown), H. Böhrer, (unknown), J. Dörsam, E. Martin	25
15	Human cytosolic adenylate kinase allelozymes; purification and characterization 1990 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Matthias Luz, (unknown), R. Heiner Schirmer, Rainer Frank	7
16	Bypass-associated air embolism during liver transplantation. 1990 ·PubMed ·H. Böhrer, Matthias Luz	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact